| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.054 | 0.9 |